FDG-PET/CT vs. Non-FDG Tracers in Less Explored Domains, An Issue of PET Clinics: The Clinics: Internal Medicine, cartea 17-3
Editat de Sandip Basu, Rakesh Kumar, Abass Alavien Limba Engleză Hardback – 21 iun 2022
Din seria The Clinics: Internal Medicine
- 5%
Preț: 394.41 lei - 15%
Preț: 503.11 lei - 5%
Preț: 608.74 lei - 5%
Preț: 466.20 lei - 5%
Preț: 633.40 lei - 5%
Preț: 574.16 lei - 5%
Preț: 599.73 lei - 5%
Preț: 600.12 lei - 5%
Preț: 599.98 lei - 5%
Preț: 600.03 lei - 5%
Preț: 600.34 lei - 5%
Preț: 599.27 lei - 5%
Preț: 616.99 lei - 5%
Preț: 464.77 lei - 5%
Preț: 465.73 lei - 5%
Preț: 466.02 lei - 5%
Preț: 536.41 lei - 5%
Preț: 535.73 lei - 5%
Preț: 466.46 lei - 5%
Preț: 532.76 lei - 5%
Preț: 468.73 lei - 5%
Preț: 465.73 lei - 5%
Preț: 449.04 lei - 5%
Preț: 451.15 lei - 5%
Preț: 575.59 lei - 5%
Preț: 534.89 lei - 5%
Preț: 551.34 lei - 5%
Preț: 515.34 lei - 5%
Preț: 465.10 lei - 5%
Preț: 600.54 lei - 5%
Preț: 599.72 lei - 5%
Preț: 590.42 lei - 5%
Preț: 481.95 lei - 25%
Preț: 463.36 lei - 5%
Preț: 634.80 lei - 25%
Preț: 461.96 lei - 5%
Preț: 666.99 lei - 5%
Preț: 666.70 lei - 5%
Preț: 633.37 lei - 5%
Preț: 637.44 lei - 5%
Preț: 666.81 lei - 5%
Preț: 670.00 lei - 5%
Preț: 337.63 lei - 5%
Preț: 793.48 lei - 5%
Preț: 667.38 lei - 5%
Preț: 666.84 lei - 5%
Preț: 655.22 lei - 5%
Preț: 633.37 lei - 5%
Preț: 633.59 lei
Preț: 582.64 lei
Preț vechi: 613.31 lei
-5% Nou
Puncte Express: 874
Preț estimativ în valută:
103.10€ • 120.24$ • 90.53£
103.10€ • 120.24$ • 90.53£
Carte disponibilă
Livrare economică 26 decembrie 25 - 09 ianuarie 26
Livrare express 11-17 decembrie pentru 218.52 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323897181
ISBN-10: 0323897185
Pagini: 240
Dimensiuni: 263 x 186 x 20 mm
Greutate: 4.5 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
ISBN-10: 0323897185
Pagini: 240
Dimensiuni: 263 x 186 x 20 mm
Greutate: 4.5 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
Cuprins
Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing MisconceptionsAn Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine Neoplasms18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic MalignanciesMolecular Imaging Assessment of Androgen Deprivation Therapy in Prostate CancerMolecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2- [18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers18F-FDG Versus Non-FDG PET Tracers in Multiple MyelomaRole of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain TumorsFibroblast Activation Protein Inhibitor TheranosticsPET-CTBased Quantitative Parameters for Assessment of Treatment Response and Disease Activity in Cancer and Noncancerous DisordersPositron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such SettingsNonmalignant Thoracic Disorders: An Appraisal of Fluorodeoxyglucose and Non>fluorodeoxyglucose PET/Computed Tomography ApplicationsFluorodeoxyglucose PET/Computed Tomography in Evaluation of Prosthetic Joints and Diabetic Foot: A Comparative Perspective with Other Functional Imaging ModalitiesUtility of PET/Computed Tomography in Infection and Inflammation ImagingRole of Fluorodeoxyglucose-PET in Interventional Radiology